Perrigo
PRGO
$37.42
Share price
0.11%
Change (1 day)
-1.71%
Change (1 year)
Categories
P/S ratio for Perrigo (PRGO)
P/S ratio as of February 2023 (TTM): 1.14
According to Perrigo's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.14471. At the end of 2022 the company had a P/S ratio of 1.09.
P/S ratio history for Perrigo from 2001 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 1.09 | -13.25% |
| 2021 | 1.26 | 4.3% |
| 2020 | 1.21 | -17.06% |
| 2019 | 1.45 | 30.6% |
| 2018 | 1.11 | -55.16% |
| 2017 | 2.48 | 9.82% |
| 2016 | 2.26 | -41.61% |
| 2015 | 3.87 | -31.4% |
| 2014 | 5.64 | 4.48% |
| 2013 | 5.40 | 80.21% |
| 2012 | 3.00 | -2.19% |
| 2011 | 3.06 | 31.99% |
| 2010 | 2.32 | 35.97% |
| 2009 | 1.71 | 17.13% |
| 2008 | 1.46 | -30.67% |
| 2007 | 2.10 | 83.49% |
| 2006 | 1.15 | 0.68% |
| 2005 | 1.14 | -15.04% |
| 2004 | 1.34 | 2.07% |
| 2003 | 1.31 | 27.62% |
| 2002 | 1.03 | -3.37% |
| 2001 | 1.06 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 United Therapeutics UTHR | 6.45 | 463.34% | 🇺🇸 USA |
 Endo International
ENDPQ | 0.0087 | -99.24% | 🇮🇪 Ireland |
 Intercept Pharmaceuticals
ICPT | 2.29 | 100.00% | 🇺🇸 USA |
 Catalent CTLT | 2.00 | 74.48% | 🇺🇸 USA |